Sunitinib
Overview
Sunitinib is an oral, small molecule multi-targeted receptor tyrosine kinase inhibitor that is used to treat cancer. It is known for its efficacy in inhibiting processes that result in tumor growth and cancer metastasis.
API suppliers (1)
Suppliers of Sunitinib evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
1 of 1 holds a GMP certificate on record in the EU or UK registers
- SHILPA MEDICARE LTDIndia1 active DMF GMP on record
Therapeutic areas
Do you supply Sunitinib? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.